HomeNDC LookupRxCUI directory › RxCUI 857224

Sevelamer hydrochloride 800 MG Oral Tablet — RxCUI 857224

RxNorm drug concept · Semantic clinical drug
RxCUI 857224 Semantic clinical drug · SCD ● Current RxNorm concept 13 FDA products 16 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI857224
Official nameSevelamer hydrochloride 800 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assevelamer HCl 800 MG Oral Tablet
FDA products mapped13
Package NDCs mapped16
Reported Medicaid activity (SDUD)12,915 prescriptions · 22 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Sevelamer: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • When your kidneys aren't working properly, they can't remove phosphorus from your blood the way they normally would. Dialysis helps, but it doesn't always bring phosphorus down eno...
  • What exactly does sevelamer do, and why do I need it if I'm on dialysis?
  • Yes, timing really matters here. Sevelamer needs to be taken with each meal because it works by binding to phosphate in the food you're eating right then. If you take it without fo...
  • Does it matter when I take it — can I just take all my doses at once?
📖 Read our full Sevelamer guide →

🕸️ Concept Web — How Sevelamer hydrochloride 800 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Sevelamer hydrochloride 800 MG Oral Tablet RxCUI 857224

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Sevelamer 214824
    • Sevelamer hydrochloride 237125
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • RenaGel 135118
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Sevelamer Oral Tablet 374639
    • Sevelamer hydrochloride Oral Tablet 2645341
    • Sevelamer Oral Product 1159078
    • Sevelamer Pill 1159079
    • Sevelamer hydrochloride Oral Product 2663265
    • Sevelamer hydrochloride Pill 2661575
    • Sevelamer Oral Tablet [RenaGel] 368161
    • Sevelamer hydrochloride Oral Tablet [RenaGel] 2657007
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Sevelamer hydrochloride 800 MG 857223
    • Sevelamer hydrochloride 800 MG Oral Tablet [RenaGel] 857226
    • Sevelamer hydrochloride 800 MG [RenaGel] 857225

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Sevelamer hydrochloride 800 MG SCDC · 857223
  • Sevelamer Oral Tablet SCDF · 374639
  • Sevelamer hydrochloride Oral Tablet SCDFP · 2645341
  • Sevelamer Oral Product SCDG · 1159078
  • Sevelamer Pill SCDG · 1159079
  • Sevelamer hydrochloride Oral Product SCDGP · 2663265
  • Sevelamer hydrochloride Pill SCDGP · 2661575

Brand-Name Concepts

  • Sevelamer hydrochloride 800 MG Oral Tablet [RenaGel] SBD · 857226
  • Sevelamer hydrochloride 800 MG [RenaGel] SBDC · 857225
  • Sevelamer Oral Tablet [RenaGel] SBDF · 368161
  • Sevelamer hydrochloride Oral Tablet [RenaGel] SBDFP · 2657007
  • RenaGel Oral Product SBDG · 1180736
  • RenaGel Pill SBDG · 1180737
  • RenaGel BN · 135118

📦 FDA Products & Package NDCs

13 products · 16 package NDCs
16 package NDCs map to RxCUI 857224 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00904-7209-06 50 BLISTER PACK in 1 CARTON (0904-7209-06) / 1 TABLET, FILM... sevelamer hydrochloride Major Pharmaceuticals 2024-08-19
33342-0241-65 360 TABLET, FILM COATED in 1 BOTTLE (33342-241-65) Sevelamer Hydrochloride Macleods Pharmaceuticals Limited 2023-05-26
33342-0242-07 30 TABLET, FILM COATED in 1 BOTTLE (33342-242-07) Sevelamer Hydrochloride Macleods Pharmaceuticals Limited 2023-05-26
33342-0242-57 180 TABLET, FILM COATED in 1 BOTTLE (33342-242-57) Sevelamer Hydrochloride Macleods Pharmaceuticals Limited 2023-05-26
55154-2647-00 10 BLISTER PACK in 1 BAG (55154-2647-0) / 1 TABLET, FILM CO... sevelamer hydrochloride Cardinal Health 107, LLC 2025-02-25
59651-0087-36 360 TABLET, FILM COATED in 1 BOTTLE (59651-087-36) SEVELAMER HYDROCHLORIDE Aurobindo Pharma Limited 2023-07-11
59651-0088-18 180 TABLET, FILM COATED in 1 BOTTLE (59651-088-18) SEVELAMER HYDROCHLORIDE Aurobindo Pharma Limited 2023-07-11
60687-0449-01 100 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-449-01) / 1 TAB... Sevelamer Hydrochloride American Health Packaging 2020-01-22
68462-0446-26 360 TABLET, FILM COATED in 1 BOTTLE (68462-446-26) sevelamer hydrochloride Glenmark Pharmaceuticals Inc., USA 2019-02-08
68462-0446-30 30 TABLET, FILM COATED in 1 BOTTLE (68462-446-30) sevelamer hydrochloride Glenmark Pharmaceuticals Inc., USA 2019-02-08
68462-0447-18 180 TABLET, FILM COATED in 1 BOTTLE (68462-447-18) sevelamer hydrochloride Glenmark Pharmaceuticals Inc., USA 2019-02-08
68462-0447-30 30 TABLET, FILM COATED in 1 BOTTLE (68462-447-30) sevelamer hydrochloride Glenmark Pharmaceuticals Inc., USA 2019-02-08
70710-2058-08 180 TABLET, FILM COATED in 1 BOTTLE (70710-2058-8) Sevelamer Hydrochloride Zydus Pharmaceuticals USA Inc. 2025-03-01
70748-0173-26 180 TABLET in 1 BOTTLE (70748-173-26) Sevelamer hydrochloride Lupin Pharmaceuticals, Inc. 2022-02-25
72162-2501-02 180 TABLET, FILM COATED in 1 BOTTLE (72162-2501-2) Sevelamer Hydrochloride Bryant Ranch Prepack 2025-05-15
72603-0148-01 180 TABLET, FILM COATED in 1 BOTTLE (72603-148-01) sevelamer hydrochloride NorthStar RxLLC 2023-05-23
Observed labelers: Glenmark Pharmaceuticals Inc., USA (4) · Macleods Pharmaceuticals Limited (3) · Aurobindo Pharma Limited (2) · American Health Packaging (1) · Bryant Ranch Prepack (1) · Cardinal Health 107, LLC (1) · +4 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.